|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 96 No. 2 (July 15), 2000:
pp. 635-639
Higher-grade transformation of follicle center lymphoma is
associated with somatic mutation of the 5' noncoding regulatory
region of the BCL-6 gene
Izidore S. Lossos and
Ronald Levy
From the Division of Oncology, Department of Medicine, Stanford
University Medical Center, Stanford, CA.
Follicle center lymphoma (FCL) is an indolent low-grade B-cell
non-Hodgkin's lymphoma (NHL) that frequently transforms to aggressive
diffuse large B-cell lymphoma (DLBCL). Histologic transformation of FCL
is commonly associated with accumulation of secondary genetic alterations. The BCL-6 gene is altered by
chromosomal rearrangements and mutations clustering in its 5'
noncoding regulatory region in up to 70% of primary DLBCL, but in a
significantly smaller subset of FCL. Previous studies have shown that
both chromosomal rearrangements and mutations could deregulate
BCL-6 expression. To evaluate the association between
progressive accumulation of BCL-6 regulatory region mutations
and the histologic transformation of FCL, we analyzed by extensive
cloning and sequencing paired biopsy specimens obtained at the time of
FCL diagnosis and transformation (6 patients) or FCL relapse (3 patients). In an additional patient, biopsy specimens obtained at the
time of diagnosis, FCL relapse, and subsequent transformation to DLBCL
were evaluated. The presence of identical mutations in the paired
diagnosis and posttransformation DLBCL specimens confirmed the common
clonal origin of both the pretransformation and the posttransformation
lymphomas. No new mutations in the 5' noncoding regulatory region
of the BCL-6 gene were detected in any of the specimens
evaluated at the time of FCL relapse. In contrast, 5 of the 7 transformed specimens contained new mutations not found in the paired
original biopsy specimens obtained at the time of FCL diagnosis or
relapse. The number of these new mutations ranged from 1 to 6 per
specimen. Some of the new mutations tended to cluster in certain areas
of the 5' noncoding regulatory region of the BCL-6 gene.
Our results show that transformation of FCL to DLBCL is associated with
accumulation of new mutations in the 5' noncoding regulatory
region of the BCL-6 gene, that by deregulation of the
BCL-6 gene expression may play a role in lymphoma transformation.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
Y.-W. Chen, X.-T. Hu, A. C. Liang, W.-Y. Au, C.-C. So, M. L. Wong, L. Shen, Q. Tao, K.-M. Chu, Y.-L. Kwong, et al.
High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6-deregulating mutations, in gastric lymphoma
Blood,
October 1, 2006;
108(7):
2373 - 2383.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Margalit, H. Amram, N. Amariglio, A. J. Simon, S. Shaklai, G. Granot, N. Minsky, A. Shimoni, A. Harmelin, D. Givol, et al.
BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma
Blood,
February 15, 2006;
107(4):
1599 - 1607.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. R. Miles, D. K. Crockett, M. S. Lim, and K. S. J. Elenitoba-Johnson
Analysis of BCL6-interacting Proteins by Tandem Mass Spectrometry
Mol. Cell. Proteomics,
December 1, 2005;
4(12):
1898 - 1909.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Freedman
Biology and Management of Histologic Transformation of Indolent Lymphoma
Hematology,
January 1, 2005;
2005(1):
314 - 320.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Lin, D. K. Crockett, S. D. Jenson, M. S. Lim, and K. S. J. Elenitoba-Johnson
Quantitative Proteomic and Transcriptional Analysis of the Response to the p38 Mitogen-activated Protein Kinase Inhibitor SB203580 in Transformed Follicular Lymphoma Cells
Mol. Cell. Proteomics,
August 1, 2004;
3(8):
820 - 833.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Hjortoe, L. C. Petersen, T. Albrektsen, B. B. Sorensen, P. L. Norby, S. K. Mandal, U. R. Pendurthi, and L. V. M. Rao
Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration
Blood,
April 15, 2004;
103(8):
3029 - 3037.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Akasaka, I. S. Lossos, and R. Levy
BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma
Blood,
August 15, 2003;
102(4):
1443 - 1448.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. S. J. Elenitoba-Johnson, S. D. Jenson, R. T. Abbott, R. A. Palais, S. D. Bohling, Z. Lin, S. Tripp, P. J. Shami, L. Y. Wang, R. W. Coupland, et al.
Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy
PNAS,
June 10, 2003;
100(12):
7259 - 7264.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Martinez-Climent, A. A. Alizadeh, R. Segraves, D. Blesa, F. Rubio-Moscardo, D. G. Albertson, J. Garcia-Conde, M. J. S. Dyer, R. Levy, D. Pinkel, et al.
Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations
Blood,
April 15, 2003;
101(8):
3109 - 3117.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S A Pileri, E Sabattini, P Rosito, P L Zinzani, S Ascani, G Fraternali-Orcioni, B Gamberi, M Piccioli, D Vivenza, B Falini, et al.
Primary follicular lymphoma of the testis in childhood: an entity with peculiar clinical and molecular characteristics
J. Clin. Pathol.,
September 1, 2002;
55(9):
684 - 688.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. S. Lossos, A. A. Alizadeh, M. Diehn, R. Warnke, Y. Thorstenson, P. J. Oefner, P. O. Brown, D. Botstein, and R. Levy
Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c-myc and its regulated genes
PNAS,
June 25, 2002;
99(13):
8886 - 8891.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-J. Artiga, A.-I. Saez, C. Romero, M. Sanchez-Beato, M.-S. Mateo, C. Navas, M. Mollejo, and M. A. Piris
A Short Mutational Hot Spot in the First Intron of BCL-6 Is Associated with Increased BCL-6 Expression and with Longer Overall Survival in Large B-Cell Lymphomas
Am. J. Pathol.,
April 1, 2002;
160(4):
1371 - 1380.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
